These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31170959)

  • 21. The MDM2 antagonist nutlin-3 sensitizes p53-null neuroblastoma cells to doxorubicin via E2F1 and TAp73.
    Peirce SK; Findley HW
    Int J Oncol; 2009 May; 34(5):1395-402. PubMed ID: 19360352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 Suppresses E2F1-dependent PLK1 expression upon DNA damage by forming p53-E2F1-DNA complex.
    Zhou Z; Cao JX; Li SY; An GS; Ni JH; Jia HT
    Exp Cell Res; 2013 Dec; 319(20):3104-15. PubMed ID: 24076372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depletion of TFAP2E attenuates adriamycin-mediated apoptosis in human neuroblastoma cells.
    Hoshi R; Watanabe Y; Ishizuka Y; Hirano T; Nagasaki-Maeoka E; Yoshizawa S; Uekusa S; Kawashima H; Ohashi K; Sugito K; Fukuda N; Nagase H; Soma M; Ozaki T; Koshinaga T; Fujiwara K
    Oncol Rep; 2017 Apr; 37(4):2459-2464. PubMed ID: 28260105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E2F1 and E2F2 induction in response to DNA damage preserves genomic stability in neuronal cells.
    Castillo DS; Campalans A; Belluscio LM; Carcagno AL; Radicella JP; Cánepa ET; Pregi N
    Cell Cycle; 2015; 14(8):1300-14. PubMed ID: 25892555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Hydroxyethyl methacrylate-induced apoptosis through the ATM- and p53-dependent intrinsic mitochondrial pathway.
    Schweikl H; Petzel C; Bolay C; Hiller KA; Buchalla W; Krifka S
    Biomaterials; 2014 Mar; 35(9):2890-904. PubMed ID: 24411679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Identifying the Importance of MT-3 Expression for Neuroblastoma Cells].
    Eckschlager T; Vícha A; Jenčová P; Merlos R; Dostálová S; Buchtelová H; Strmiska V; Michálek P; Heger Z; Adam V
    Klin Onkol; 2018; 31(Supplementum1):145-147. PubMed ID: 29808689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA-PKcs deficiency sensitizes the human hepatoma HepG2 cells to cisplatin and 5-fluorouracil through suppression of the PI3K/Akt/NF-κB pathway.
    Fang Y; Chai Z; Wang D; Kuang T; Wu W; Lou W
    Mol Cell Biochem; 2015 Jan; 399(1-2):269-78. PubMed ID: 25348361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miRNA-558 promotes tumorigenesis and aggressiveness of neuroblastoma cells through activating the transcription of heparanase.
    Qu H; Zheng L; Pu J; Mei H; Xiang X; Zhao X; Li D; Li S; Mao L; Huang K; Tong Q
    Hum Mol Genet; 2015 May; 24(9):2539-51. PubMed ID: 25616966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E2F1-dependent pathways are involved in amonafide analogue 7-d-induced DNA damage, G2/M arrest, and apoptosis in p53-deficient K562 cells.
    Li Y; Shao J; Shen K; Xu Y; Liu J; Qian X
    J Cell Biochem; 2012 Oct; 113(10):3165-77. PubMed ID: 22593008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. microRNA‑202 suppresses MYCN expression under the control of E2F1 in the neuroblastoma cell line LAN‑5.
    Li YG; He JH; Yu L; Hang ZP; Li W; Shun WH; Huang GX
    Mol Med Rep; 2014 Feb; 9(2):541-6. PubMed ID: 24337320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.
    Powers JT; Hong S; Mayhew CN; Rogers PM; Knudsen ES; Johnson DG
    Mol Cancer Res; 2004 Apr; 2(4):203-14. PubMed ID: 15140942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 53BP1 depletion causes PARP inhibitor resistance in ATM-deficient breast cancer cells.
    Hong R; Ma F; Zhang W; Yu X; Li Q; Luo Y; Zhu C; Jiang W; Xu B
    BMC Cancer; 2016 Sep; 16(1):725. PubMed ID: 27613518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex.
    Hofland K; Petersen BO; Falck J; Helin K; Jensen PB; Sehested M
    Clin Cancer Res; 2000 Apr; 6(4):1488-97. PubMed ID: 10778981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
    Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
    BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rad18 is a transcriptional target of E2F3.
    Varanasi L; Do PM; Goluszko E; Martinez LA
    Cell Cycle; 2012 Mar; 11(6):1131-41. PubMed ID: 22391204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isoliquiritigenin as a cause of DNA damage and inhibitor of ataxia-telangiectasia mutated expression leading to G2/M phase arrest and apoptosis in oral squamous cell carcinoma.
    Hsia SM; Yu CC; Shih YH; Yuanchien Chen M; Wang TH; Huang YT; Shieh TM
    Head Neck; 2016 Apr; 38 Suppl 1():E360-71. PubMed ID: 25580586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA-damaging drug-induced apoptosis sensitized by N-myc in neuroblastoma cells.
    Li T; Wang L; Ke XX; Gong XY; Wan JH; Hao XW; Xu M; Xiang Z; Cui ZB; Cui H
    Cell Biol Int; 2012 Apr; 36(4):331-7. PubMed ID: 21929510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promoter occupancy of MLL1 histone methyltransferase seems to specify the proliferative and apoptotic functions of E2F1 in a tumour microenvironment.
    Swarnalatha M; Singh AK; Kumar V
    J Cell Sci; 2013 Oct; 126(Pt 20):4636-46. PubMed ID: 23868976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of autophagy in chemoresistance: regulation of the ATM-mediated DNA-damage signaling pathway through activation of DNA-PKcs and PARP-1.
    Yoon JH; Ahn SG; Lee BH; Jung SH; Oh SH
    Biochem Pharmacol; 2012 Mar; 83(6):747-57. PubMed ID: 22226932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dependence receptor UNC5D mediates nerve growth factor depletion-induced neuroblastoma regression.
    Zhu Y; Li Y; Haraguchi S; Yu M; Ohira M; Ozaki T; Nakagawa A; Ushijima T; Isogai E; Koseki H; Nakamura Y; Kong C; Mehlen P; Arakawa H; Nakagawara A
    J Clin Invest; 2013 Jul; 123(7):2935-47. PubMed ID: 23778138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.